Search Within

David Scheinberg

  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (8)
  3. Book Section (1)
Groups
  1. Adult Leukemia (26)
  2. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (26)
  3. Center for Hematologic Malignancies (26)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (26)
  5. Department of Medicine (26)
  6. GSK Faculty (26)

More Groups

People
  1. Tao Dao (7)
  2. Peter Maslak (6)
  3. Katherine Panageas (5)
  4. Lee Krug (5)
  5. Martin Klatt (5)
  6. Alan Houghton (4)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (1)
  5. 2019 (2)
  6. 2017 (1)

More Years

Publications
  1. Blood (2)
  2. Cancer Immunology Research (2)
  3. Cancer Immunology, Immunotherapy (2)
  4. Clinical Cancer Research (2)
  5. Journal of Clinical Oncology (2)
  6. Nature Medicine (2)

More Publications

Publishers
  1. American Association for Cancer Research (7)
  2. Nature Publishing Group (3)
  3. Springer (3)
  4. American Society of Clinical Oncology (2)
  5. American Society of Hematology (2)
  6. Biomed Central Ltd (2)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neopeptide diversity and similarity to the unmutated immunopeptidome is associated with response to immune checkpoint blockade therapy
    Meeting Abstract

    Klatt, M.; Molvi, Z.; Panageas, K.; Wells, D.; Hellmann, M.; Merghoub, T.; Wolchok, J.; O'Reilly, R.; Keller, U.; Scheinberg, D.
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
    Journal Article

    Chandran, S. S.; Ma, J.; Klatt, M. G.; Dündar, F.; Bandlamudi, C.; Razavi, P.; Wen, H. Y.; Weigelt, B.; Zumbo, P.; Fu, S. N.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancer
    Journal Article

    Dao, T.; Klatt, M. G.; Korontsvit, T.; Mun, S. S.; Guzman, S.; Mattar, M.; Zivanovic, O.; Kyi, C. K.; Socci, N. D.; O’Cearbhaill, R. E.; more...
    Cancer Immunology, Immunotherapy (2021)

    Fulltext@MSK | Save
  • Identification of the targets of T-cell receptor therapeutic agents and cells by use of a high-throughput genetic platform
    Journal Article

    Gejman, R. S.; Jones, H. F.; Klatt, M. G.; Chang, A. Y.; Oh, C. Y.; Chandran, S. S.; Korontsvit, T.; Zakahleva, V.; Dao, T.; Klebanoff, C. A.; more...
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
    Meeting Abstract

    Chandran, S.; Ma, J.; Klatt, M. G.; Dundar, F.; Zumbo, P.; Femia, M. R.; Betel, D.; Scheinberg, D. A.; Baker, B. M.; Klebanoff, C. A.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
    Meeting Abstract

    Ma, J.; Klatt, M.; Dundar, F.; Zumbo, P.; Femia, M.; Betel, D.; Scheinberg, D.; Baker, B.; Klebanoff, C.; Chandran, S.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • A randomized phase II trial of adjuvant galinpepimut-S, WT-1 analogue peptide vaccine, after multimodality therapy for patients with malignant pleural mesothelioma
    Journal Article

    Zauderer, M. G.; Tsao, A. S.; Dao, T.; Panageas, K.; Lai, W. V.; Rimner, A.; Rusch, V. W.; Adusumilli, P. S.; Ginsberg, M. S.; Gomez, D.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Randomized phase II study of adjuvant WT1 vaccine (SLS-001) for malignant pleural mesothelioma (MPM) after multimodality therapy
    Meeting Abstract

    Zauderer, M. G.; Dao, T.; Rusch, V. W.; Ginsberg, M. S.; Tsao, A. S.; Panageas, K.; Stergiou, A. M.; Scheinberg, D. A.; Krug, L. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Kinase regulation of human MHC class i molecule expression on cancer cells
    Journal Article

    Brea, E. J.; Oh, C. Y.; Manchado, E.; Budhu, S.; Gejman, R. S.; Mo, G.; Mondello, P.; Han, J. E.; Jarvis, C. A.; Ulmert, D.; more...
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save
  • Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
    Journal Article

    Şenbabaoğlu, Y.; Gejman, R. S.; Winer, A. G.; Liu, M.; Van Allen, E. M.; de Velasco, G.; Miao, D.; Ostrovnaya, I.; Drill, E.; Luna, A.; more...
    Genome Biology (2016)

    Fulltext@MSK | Save